Kaken Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 6.70% vs 3.95% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 114.26% vs -487.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19,254.00",
          "val2": "18,045.00",
          "chgp": "6.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-436.00",
          "val2": "-3,756.00",
          "chgp": "88.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.00",
          "val2": "9.00",
          "chgp": "44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-745.00",
          "val2": "-2,010.00",
          "chgp": "62.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "746.00",
          "val2": "-5,230.00",
          "chgp": "114.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-75.50%",
          "val2": "-243.00%",
          "chgp": "16.75%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -18.25% vs 30.52% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -84.63% vs 73.77% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76,871.00",
          "val2": "94,035.00",
          "chgp": "-18.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,426.00",
          "val2": "23,590.00",
          "chgp": "-89.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "45.00",
          "val2": "28.00",
          "chgp": "60.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-724.00",
          "val2": "-2,025.00",
          "chgp": "64.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,144.00",
          "val2": "13,945.00",
          "chgp": "-84.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.70%",
          "val2": "223.70%",
          "chgp": "-23.54%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

19,254.00

18,045.00

6.70%

Operating Profit (PBDIT) excl Other Income

-436.00

-3,756.00

88.39%

Interest

13.00

9.00

44.44%

Exceptional Items

-745.00

-2,010.00

62.94%

Consolidate Net Profit

746.00

-5,230.00

114.26%

Operating Profit Margin (Excl OI)

-75.50%

-243.00%

16.75%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 6.70% vs 3.95% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 114.26% vs -487.41% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

76,871.00

94,035.00

-18.25%

Operating Profit (PBDIT) excl Other Income

2,426.00

23,590.00

-89.72%

Interest

45.00

28.00

60.71%

Exceptional Items

-724.00

-2,025.00

64.25%

Consolidate Net Profit

2,144.00

13,945.00

-84.63%

Operating Profit Margin (Excl OI)

-11.70%

223.70%

-23.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -18.25% vs 30.52% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -84.63% vs 73.77% in Mar 2025

All Annual Results